Skip to content
Menu

Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $65

Benzinga Newsdesk 2 days ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Wells Fargo analyst James Feldman maintains National Health Investors (NYSE:NHI) with a Equal-Weight and lowers the price target from $68 to $65.

Wells Fargo analyst James Feldman maintains National Health Investors (NYSE:NHI) with a Equal-Weight and lowers the price target from $68 to $65.

Read at benzinga.com